Posts by Sandra Ansanay-Alex
KBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development and manufacturing services facility in Plan-les-Ouates in Geneva, Switzerland. The ~8 700 m2 integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell…
Read MoreScaling Up Sales
From the idea to the market, grow your business with a marketing and sales programme Scaling Up Sales is a program supported by the Service de la promotion de l’économie et de l’innovation (SPEI) of the Canton of Vaud, in partnership with Innovaud and the Fondation pour l’Innovation Technologique (FIT). This program supports SMEs…
Read MoreThe canton of Vaud keeps on backing the FIT
The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT) This is excellent news for the world of innovation in Western Switzerland. The canton of Vaud announced the renewal of its financial contribution to the Fondation pour l’Innovation Technologique to the extent of CHF 16…
Read MoreLonza opens a new production facility in Stein (CH)
Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will be invested and the plant is expected to be completed in 2026. “This strategic investment completes our offering in drug product and strengthens our position as a leading CDMO with an unparalleled breadth of offerings across…
Read MoreVaud invests CHF 178 Million in Life Sciences
To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne in Life Sciences, the State Council is requesting five investment credits totaling CHF 178.71 million from the Grand Council. In Dorigny, these investments would allow the construction of a life sciences building and, in…
Read MoreSupervene: growing humain vein tissues
ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins in the lab. The joint project has received CHF 2 million in funding from the Research Council of Norway. Severe chronic venous insufficiency (CVI) is a debilitating disease afflicting millions of people around the…
Read MoreWyss Center joins life sciences cluster BioAlps
The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives, has joined BioAlps, the life sciences cluster for Western Switzerland. “We are honored that the Wyss Center for Bio and Neuroengineering has agreed to join BioAlps. This leading research center is a pioneer…
Read MoreSyNNergy
The Canton of Vaud supports companies working on the digital transition The SyNNergy programme is an initiative of the Canton of Vaud designed to support consortia of at least 3 companies, the majority of which are from Vaud, wishing to carry out an innovative project together and in connection with the digital transition. The support…
Read MoreGeneva researcher wins European Inventor’s Award
Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded for her therapeutic vaccines against cancer. The European Patent Office (EPO) awarded the two researchers the European Inventor Award 2022 in the “SME” category at a ceremony in Munich on Tuesday. The teammates have…
Read Moreten23health is building a new facility in Visp
The company plans to establish a new 5,000 m2 manufacturing facility in Visp. In October 2021, ten23 health acquired a former Swissfillon site to install its production facility. In March 2022, a first 1,000 m2 expansion was announced. The new 5,000 m2 facility will include sterile manufacturing lines plus laboratories, offices and technical areas across…
Read More